The use of MDT in the three western regions of Nepal.
D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage*; D007918:Leprosy / Q000188:drug therapy*; D009390:Nepal; D010349:Patient Compliance
D007917:Leprostatic Agents